Ideal for medical patients and adult users who covet a full-spectrum cannabis oil in a specially formulated ratio.
MediPharm Labs Corp. (TSX: LABS) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced a further expansion of its innovative, pharma-quality family of branded products with the retail introduction of CBD25:5 Release Formula.
CBD25:5 is an important breakthrough because of its specially designed release formula.Pat McCutcheon, Chief Executive Officer, MediPharm Labs
This latest brand – the third launched from MediPharm Labs' GMP-certified Canadian facility since late March – is ideal for medical patients and adult users who covet a full-spectrum cannabis oil in a specially formulated ratio of approximately 25mg/ml of CBD and 5mg/ml of THC, harnessing the properties of both cannabinoids.
"Canadians have told us loud and clear they want more and better choices at retail and MediPharm Labs is not only listening, we're acting by delivering a portfolio of quality-tested, Cannabis brands and formulated products – now including CBD25:5 – that consumers can trust for everyday use," said Pat McCutcheon, Chief Executive Officer, MediPharm Labs. "Recognizing the potential of this product, we're delighted to note that Medical Cannabis by Shoppers, Canada's major national medical platform and retailer, as well as several other private provincial distributors have now committed to bringing CBD25:5 to market with more to follow."
Initial quantities of CBD25:5 recently shipped to Medical Cannabis by shoppers, and to cannabis retailers and distributors in British Columbia and Saskatchewan. Delivering one of the more differentiated formulations on the market to multiple jurisdictions, MediPharm Labs plans to achieve full national distribution of its branded family of cannabis products, which includes CBD 25 Regular Formula and the more potent CBD 50 Plus Formula already available more broadly.
To learn more about MediPharm Labs, visit the company HQ here.
Disclaimer: Past performance is not an indicator of future performance.
Get the Latest Marijuana News &
Content in your Inbox!
All your support helps The Green Fund keep writing content for all you
marijuana enthusiasts and potential pot stock investors